Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I H Hall

Showing results (191-200 of 288) with videos related to

Pageof 29
Sort By:
Research Communications in Chemical Pathology and Pharmacology|April 1, 1989
Disposition of cisplatin derivatives -3H-cis-1,2-diaminocyclohexanedichloroplatinum (II) and 3H-cis-1,2-diaminocyclohexanemalonatoplatinum (II) in BDF1 miceC B Oswald, S D Wyrick, S G Chaney, et al.
Journal of Natural Products|March 1, 1982
Antitumor agents 50. 1 Morindaparvin-A, a new antileukemic anthraquinone, and alizarin-1-methyl ether from Morinda parvifolia, and the antileukemic activity of the related derivativesP Chang, K H Lee, T Shingu, et al.
Pharmaceutical Research|December 1, 1987
Effect of helenalin and bis(helenalinyl)malonate on nucleic acid and protein synthesis in human KB carcinoma cellsI H Hall, A A Grippo, K H Lee, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1989
The effects of boron hypolipidemic agents on LDL and HDL receptor binding and related enzyme activities of rat hepatocytes, aorta cells and human fibroblastsI H Hall, B F Spielvogel, T S Griffin, et al.
Journal of Medicinal Chemistry|January 1, 1985
Comparison of the hypolipidemic activity of cyclic vs. acyclic imidesP J Voorstad, J M Chapman, G H Cocolas, et al.
Biochemical Pharmacology|November 15, 1989
In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactoneD E Chapman, D J Holbrook, S G Chaney, et al.
Biomedica Biochimica Acta|January 1, 1987
A comparison of the S(+) and R(-) enantiomers of 5-ethyl-5-phenylhydantoin as hypolipidemic agents in rodentsI H Hall, J H Maguire, O T Wong, et al.
The Journal of Pharmacy and Pharmacology|May 24, 2001
Specific inhibition of type II inosine monophosphate dehydrogenase activity of Tmolt4 T cell human leukaemia cells by 3-methoxy and di-benzohydroxamic acids, maleic hydrazide and malonic acidsI H Hall, B J Barnes, E S Ward, et al.
Pharmaceutical Research|December 1, 1987
Hypolipidemic activity of o-(N-phthalimido)acetophenone in Sprague Dawley ratsI H Hall, D J Reynolds, O T Wong, et al.
Anticancer Research|January 19, 1999
The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazonesM C Miller, C N Stineman, J R Vance, et al.
Pageof 29

Showing results (191-200 of 288) with videos related to

Sort By:
Pageof 29
Research Communications in Chemical Pathology and Pharmacology|April 1, 1989
Disposition of cisplatin derivatives -3H-cis-1,2-diaminocyclohexanedichloroplatinum (II) and 3H-cis-1,2-diaminocyclohexanemalonatoplatinum (II) in BDF1 miceC B Oswald, S D Wyrick, S G Chaney, et al.
Journal of Natural Products|March 1, 1982
Antitumor agents 50. 1 Morindaparvin-A, a new antileukemic anthraquinone, and alizarin-1-methyl ether from Morinda parvifolia, and the antileukemic activity of the related derivativesP Chang, K H Lee, T Shingu, et al.
Pharmaceutical Research|December 1, 1987
Effect of helenalin and bis(helenalinyl)malonate on nucleic acid and protein synthesis in human KB carcinoma cellsI H Hall, A A Grippo, K H Lee, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1989
The effects of boron hypolipidemic agents on LDL and HDL receptor binding and related enzyme activities of rat hepatocytes, aorta cells and human fibroblastsI H Hall, B F Spielvogel, T S Griffin, et al.
Journal of Medicinal Chemistry|January 1, 1985
Comparison of the hypolipidemic activity of cyclic vs. acyclic imidesP J Voorstad, J M Chapman, G H Cocolas, et al.
Biochemical Pharmacology|November 15, 1989
In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactoneD E Chapman, D J Holbrook, S G Chaney, et al.
Biomedica Biochimica Acta|January 1, 1987
A comparison of the S(+) and R(-) enantiomers of 5-ethyl-5-phenylhydantoin as hypolipidemic agents in rodentsI H Hall, J H Maguire, O T Wong, et al.
The Journal of Pharmacy and Pharmacology|May 24, 2001
Specific inhibition of type II inosine monophosphate dehydrogenase activity of Tmolt4 T cell human leukaemia cells by 3-methoxy and di-benzohydroxamic acids, maleic hydrazide and malonic acidsI H Hall, B J Barnes, E S Ward, et al.
Pharmaceutical Research|December 1, 1987
Hypolipidemic activity of o-(N-phthalimido)acetophenone in Sprague Dawley ratsI H Hall, D J Reynolds, O T Wong, et al.
Anticancer Research|January 19, 1999
The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazonesM C Miller, C N Stineman, J R Vance, et al.
Pageof 29